30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Leslie Norwalk

Track

Insider profile

Currently holds positions in NuVasive Inc, ModivCare Inc, Magellan Health Inc and Neurocrine Biosciences Inc

Positions

Position Company Period
Independent Director NuVasive Inc May 1, 2014 -
Independent Director ModivCare Inc Jan. 1, 2017 -
Independent Director Magellan Health Inc March 29, 2019 -
Independent Director Neurocrine Biosciences Inc Sept. 11, 2019 -
Independent Director Endologix Inc May 1, 2015 - June 9, 2020
Director ModivCare Inc Nov. 5, 2015 - Jan. 1, 2017
Leslie Norwalk's trades of Neurocrine Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-08 2026-06-04
PlS Planned sale
6,351 -45.7%
432.14
US$3,344,936 		6,351 -45.7% 432.14 US$3,344,936
2026-05-14 2026-05-12
PlS Planned sale
76,216 +28.3%
435.56
US$3,103,681 		76,216 +28.3% 435.56 US$3,103,681
2026-05-12 2026-05-12
PrS Proposed sale
49,976
445.22
US$444,112 		49,976 445.22 US$444,112
2026-01-12 2026-01-08
PlS Planned sale
2,000 -16.1%
101.10
US$202,200 		2,000 -16.1% 101.10 US$202,200
2026-01-08 2026-01-08
PrS Proposed sale
2,000
101.00
US$202,000 		2,000 101.00 US$202,000
2025-12-17 2025-12-16
PlS Planned sale
1,190 -16.0%
155.09
US$184,558 		1,190 -16.0% 155.09 US$184,558
2025-12-17 2025-12-15
PlS Planned sale
5,000 -40.2%
152.23
US$761,144 		5,000 -40.2% 152.23 US$761,144
2025-12-15 2025-12-15
PrS Proposed sale
11,250
155.11
US$1,745,000 		11,250 155.11 US$1,745,000
2025-12-16 2025-12-12
PlS Planned sale
4,000 -24.4%
88.85
US$355,400 		4,000 -24.4% 88.85 US$355,400
2025-12-12 2025-12-12
PrS Proposed sale
4,000
88.75
US$355,000 		4,000 88.75 US$355,000
2024-07-15 2024-07-11
PlS Planned sale
1,000 -5.7%
70.00
US$70,000 		1,000 -5.7% 70.00 US$70,000
2024-07-11 2024-07-11
PrS Proposed sale
1,000
70.00
US$70,000 		1,000 70.00 US$70,000
2024-05-21 2024-05-17
PlS Planned sale
1,106 -52.7%
141.82
US$156,850 		1,106 -52.7% 141.82 US$156,850
2024-05-21 2024-05-17
PlS Planned sale
1,106 -52.7%
141.82
US$156,850 		1,106 -52.7% 141.82 US$156,850
2024-05-17 2024-05-17
PrS Proposed sale
1,106
141.91
US$156,952 		1,106 141.91 US$156,952
2024-03-19 2024-03-15
PlS Planned sale
10,590 -37.8%
51.99
US$550,574 		10,590 -37.8% 51.99 US$550,574
2024-03-15 2024-03-15
PrS Proposed sale
10,590
51.94
US$550,000 		10,590 51.94 US$550,000
2024-02-29 2024-02-27
PlS Planned sale
8,000 -100.0%
135.67
US$1,085,388 		8,000 -100.0% 135.67 US$1,085,388
2024-02-27 2024-02-27
PrS Proposed sale
8,000
135.58
US$1,084,640 		8,000 135.58 US$1,084,640